Tag Archives: strategic alternatives

Responding To Tough Markets: Restructurings In Biotech
April 14, 2022

Another day, another “restructuring” – there’s been a flurry of press releases recently using phrases like “exploring strategic alternatives”, “extending the cash runway”, and “de-prioritizing” certain R&D programs. These announcements are obviously responses to the tough market environment. In every

Leave a comment